Copertina

Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Arjun Pon Avudaiappan, Pushan Prabhakar, Rachel Siretskiy, Andrew Renshaw, Ahmed Eldefrawy, Murugesan Manoharan
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	BJUI Compass
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Time toxicity of intravesical BCG versus sequential intravesical gemcitabine and docetaxel for non‐muscle‐invasive bladder cancer
di: Jacob Hanna, et al.
Pubblicazione: (2026)

Cost‐effectiveness analysis of a biopsy‐free diagnostic strategy for prostate cancer using mpMRI and PSMA‐PET/CT
di: Joshua Yi Min Tung, et al.
Pubblicazione: (2026)

Real‐world oncological and toxicity outcomes with the Moscow strain of intravesical BCG for non‐muscle invasive bladder cancer—Implications for global shortage
di: Amandeep Arora, et al.
Pubblicazione: (2025)

Multivariable model integrating PHI and mpMRI for detecting csPCa in biopsy‐naïve men
di: Mario Dominguez Esteban, et al.
Pubblicazione: (2025)

Sociodemographic landscape of suspected prostate cancer referrals and diagnoses across North East London
di: Muhammad Haider, et al.
Pubblicazione: (2025)

MRI performance to identify clinically significant prostate cancer following focal cryo‐ablation
di: Herbert Lepor, et al.
Pubblicazione: (2025)

Emerging tools for the early detection of prostate cancer
di: Muhammad Haider, et al.
Pubblicazione: (2025)

Understanding symptom contribution to sex inequality in bladder and renal cancer stage at diagnosis
di: Yin Zhou, et al.
Pubblicazione: (2024)

Multiparametric‐magnetic resonance imaging (mp‐MRI) of the prostate and Urolift: Identifying artefact size, location and clinical implications
di: Cameron James Parkin, et al.
Pubblicazione: (2024)

The potential role of precision medicine to alleviate racial disparities in prostate, bladder and renal urological cancer care
di: Kunal K. Sindhu, et al.
Pubblicazione: (2024)

Comparison of staging MRI to re‐resection for localised bladder cancer: Narrative review
di: Hugo Klempfner, et al.
Pubblicazione: (2024)

Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancer
di: Esther H. J. Hamoen, et al.
Pubblicazione: (2025)

Effect of prior HoLEP procedure on multiparametric MRI accuracy in detection of prostate cancer
di: Austin Drysch, et al.
Pubblicazione: (2025)

Haematuria cancer risk score as a predictor of muscle‐invasive bladder cancer
di: Serdar Turan, et al.
Pubblicazione: (2025)

Does bladder outflow obstruction obfuscate the traditional clinical factors that are used to assess the risk of prostate cancer at rapid‐access diagnostic clinics?
di: Thomas Philip Cahill, et al.
Pubblicazione: (2024)

National survey of urologists' views on prostate cancer screening in the United Kingdom
di: Nikhil Mayor, et al.
Pubblicazione: (2026)

The impact of pre‐biopsy MRI and additional testing on prostate cancer screening outcomes: A rapid review
di: Abel Tesfai, et al.
Pubblicazione: (2024)

Genomic prostate score and treatment selection in favourable intermediate‐risk prostate cancer
di: Eric Margolis, et al.
Pubblicazione: (2025)

Patient experience of bladder cancer: A data linkage study
di: Snehadhar Shah, et al.
Pubblicazione: (2024)

‘It Just Makes Sense to Me’: A qualitative study exploring patient decision‐making and experiences with prostate MRI during active surveillance for prostate cancer
di: Ryan Sutherland, et al.
Pubblicazione: (2024)

Quality of English‐ and Spanish‐language online content about prostate cancer genetics: Insights into potential contributors to prostate cancer disparities
di: Sophia M. Abusamra, et al.
Pubblicazione: (2025)

Long non‐coding RNAs define favourable biology in high‐risk non‐muscle‐invasive bladder cancer
di: Rachel Weng, et al.
Pubblicazione: (2025)

Omission of contralateral biopsies in unilateral MRI‐suspicious prostate cancer has minimal impact on clinical risk assessment
di: Stijn M. van den Bosch, et al.
Pubblicazione: (2026)

Alcohol consumption among patients diagnosed with genitourinary cancers
di: Aidan Weitzner, et al.
Pubblicazione: (2025)

Bibliometric analysis of focal therapy in prostate cancer research
di: Mohammed Shahait, et al.
Pubblicazione: (2024)

Perioperative chemotherapy use and related outcomes in muscle‐invasive bladder cancer in Australia
di: Alison Hiong, et al.
Pubblicazione: (2025)

Acu‐URO17 is a highly sensitive and specific bladder cancer biomarker
di: Liwu Guo, et al.
Pubblicazione: (2024)

Predictors of adherence to surveillance cystoscopy for patients with non‐muscle invasive bladder cancer
di: Katherina Y. Chen, et al.
Pubblicazione: (2026)

Micro‐ultrasound tissue echogenicity predicts prostate cancer grade
di: Ailene E. Corona, et al.
Pubblicazione: (2026)

Understanding the long‐term impact of the COVID‐19 pandemic on non‐muscle‐invasive bladder cancer outcomes: 12‐Month follow‐up data from the international, prospective COVIDSurg Cancer study
di: Cameron E. Alexander, et al.
Pubblicazione: (2024)

Treatment preferences of patients with muscle invasive bladder cancer: A discrete choice experiment
di: Liam Mannion, et al.
Pubblicazione: (2024)

Novel neoadjuvant therapies for muscle‐invasive bladder cancer: Systematic review and meta‐analysis
di: Shugo Yajima, et al.
Pubblicazione: (2025)

Preoperative FAN score predicts survival outcomes after radical cystectomy for bladder cancer
di: Yu Ishizuya, et al.
Pubblicazione: (2026)

Utility of dynamic contrast enhancement for clinically significant prostate cancer detection
di: Eric V. Li, et al.
Pubblicazione: (2024)

Focal therapy in prostate cancer: Development, application and outcomes in the United Kingdom
di: Nadia Rokan, et al.
Pubblicazione: (2025)

Investigating the prognostic utility of GSTP1 promoter methylation in prostate cancer
di: Ruth Pidsley, et al.
Pubblicazione: (2024)

The significant costs of prostate cancer management—An analysis from a Caribbean hospital
di: Geneva Pantoja, et al.
Pubblicazione: (2025)

Impact of recreational football in men with prostate cancer undergoing androgen deprivation therapy
di: Sofia Mesquita, et al.
Pubblicazione: (2025)

Variation in harms and benefits of prostate‐specific antigen screening for prostate cancer by socio‐clinical risk factors: A rapid review
di: Abel Tesfai, et al.
Pubblicazione: (2024)

Germline homologous recombination repair (gHRR) variants in bladder cancer: Preliminary evidence and clinical implications
di: Rodolfo Hurle, et al.
Pubblicazione: (2025)